A sale to an undisclosed buyer, enabling the patient engagement platform to pursue its next stage of growth.
The client
We were engaged to sell a market-leading patient engagement platform, Project Vita. With a proven track record in its sector and a profitable P&L, Project Vita represented an exciting opportunity for investors seeking to acquire a highly skilled team and a scalable, high-impact product.
Project Vita aimed to establish a strategic partnership that would enable them to deliver on their ambitious growth strategy, targeting both multi-vertical expansion and international markets.
What we did
We worked with the shareholders, collaborating closely with the founder throughout the outreach process to ensure that we connected with the most aligned partners to help realise Project Vita’s objectives. After conducting thorough research, we engaged with over 110 potential partners, generating significant interest in this compelling partnership opportunity.
The outcome
Project Vita was successfully acquired by an undisclosed buyer. The sale ensured that the experienced team remains integral to the business, enabling them to drive the company’s growth ambitions and continue enhancing patient experiences. Using their cutting-edge technology, Project Vita will play a pivotal role in shaping the future of patient experience.
We are pleased to have supported the management and their owners deliver a transition to a new ownership structure to facilitate future growth. We are excited to see how Project Vita continues to grow in the future and support more patients.
Ian Barton commented



